Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn:
“Wow! What a fantastic ASCO-POST editorial board meeting at ASCO 25 energized by visionary leaders in oncology Jame Abraham, George Demetri, Omid Hamid, Allison Betof Warner et al.
Phenomenal discussions on how to disseminate cutting-edge cancer research updates for all. Nothing beats face-to-face meetings and real-time inputs!”
More posts featuring ASCO 2025 on OncoDaily.